Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksGLS
resources
GLS

Alivus Life Sciences Ltd.

NSE: ALIVUS
BSE: 543322
Sector: Healthcare
Industry: Pharmaceuticals
1,130.10-12.9 (-1.13%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Alivus Life Sciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Alivus Life Sciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Analyst / Investor Meet23 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Institutional Investor Meeting - Plant Visit
  • Analyst / Investor Meet10 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Analyst / Institutional Investor Meeting.
  • Analyst / Investor Meet4 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
  • Analyst / Investor Meet20 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
  • Analyst / Investor Meet19 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
  • Analyst / Investor Meet15 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    We hereby confirm that we have uploaded audio recording of the Q4 & FY2025-26 Earnings Call held on May 15, 2026 on the website of the Company.
  • Press Release / Media Release14 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Enclosed please find herewith Press Release of the Company for the fourth quarter and year ended March 31, 2026.
  • Allotment of ESOP / ESPS14 May 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Enclosed please find herewith intimation with respect to allotment of Equity Shares under the "Employee Stock Option Scheme, 2021".
  • Outcome of Board Meeting14 May 2026
    Board Meeting Outcome for Audited Financial Results And Recommendation Of Final Dividend
    We wish to inform you that the Board of Directors at its meeting held today i.e., May 14, 2026, has inter-alia approved the Audited Financial Results for the quarter and year ended March ....
  • Analyst / Investor Meet8 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Enclosed please find herewith the details of Earnings Call slated for Friday, May 15, 2026 from 8:30 a.m. to 9:30 a.m. (IST), for your information and record.
  • Closure of Trading Window7 May 2026
    Closure of Trading Window
    Intimation of closure of trading window from April 1, 2026 to May 16, 2026 (both days inclusive) for the purpose of approval of Audited Financial Results for the quarter and year ended March 31, 2026.
  • Board Meeting7 May 2026
    Board Meeting Intimation for Considering And Approving Audited Financial Results Of The Company For The Quarter And Year Ended 31St March, 2026 And To Consider And Recommend Dividend, If Any, On Equity Shares For The Year Ended March 31, 2026.
    Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve the Audited Financial ....
  • Reg.24(A)-Annual Secretarial Compliance7 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Please find attached herewith Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2026.
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A29 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • General21 Mar 2026
    Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
    Kindly refer attachment.
  • Analyst / Investor Meet12 Mar 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
  • Analyst / Investor Meet6 Mar 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
  • General25 Feb 2026
    Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations')
    Kindly refer attachment.
  • General16 Feb 2026
    Announcement Under Regulation 30 - Updates
    Kindly refer the enclosed attachment.
  • Analyst / Investor Meet2 Feb 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Kindly refer enclosed attachment.

Frequently Asked Questions

Where can I download the annual report of Alivus Life Sciences Ltd.?
Annual reports of Alivus Life Sciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Alivus Life Sciences Ltd.?
Quarterly earnings results and presentations of Alivus Life Sciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Alivus Life Sciences Ltd. publish earnings call transcripts?
Earnings call transcripts of Alivus Life Sciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Alivus Life Sciences Ltd.?
Investor presentations and annual day presentations of Alivus Life Sciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Alivus Life Sciences Ltd.?
Corporate announcements and regulatory filings of Alivus Life Sciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Alivus Life Sciences Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Alivus Life Sciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Alivus Life Sciences Ltd.?
The ISIN (International Securities Identification Number) of Alivus Life Sciences Ltd. is INE03Q201024. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Alivus Life Sciences Ltd. listed?
Alivus Life Sciences Ltd. is listed on NSE and BSE. The NSE symbol is GLS and the BSE code is -.
Where can I find the shareholding pattern of Alivus Life Sciences Ltd.?
The quarterly shareholding pattern of Alivus Life Sciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Alivus Life Sciences Ltd. on Sharpely?
Share price data for Alivus Life Sciences Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.